WHO Issues Update on MERS-CoV Cases in the Republic of Korea


The outbreak of Middle East Respiratory Syndrome (MERS), in the Republic of Korea continues to evolve. The World Health Organization (WHO) says that it is in close contact with the country’s government and Ministry of Health, and is receiving information as soon as facts are confirmed.

The quality of reporting has allowed almost real-time insight into the dynamics of the outbreak. Aggressive contact tracing and testing for infection may help explain the rapid expansion of the outbreak. Human-to-human transmission has been documented. At this stage, WHO has no evidence of sustained transmission in the community.

Korea’s first or “index” case was confirmed on May 20 and reported to WHO the same day. The case occurred in a 68-year-old Korean national with a recent history of travel to four countries in the Middle East. The case was asymptomatic during his return flight to Korea on May 4. He developed symptoms on May 11 and subsequently sought care at two out-patient clinics and two hospitals, creating multiple opportunities for exposure among health care workers and other patients.

As the index case provided no history of potential exposure to the virus, MERS was not suspected and the patient was not treated in isolation. Efforts are under way to gather more information about exposures during the patient’s travels in the Middle East.

The outbreak is the largest reported outside the Kingdom of Saudi Arabia, where the disease first emerged in April 2012 and the vast majority of cases have occurred.

To date, contact tracing has identified a total of 25 laboratory-confirmed cases, including the index case and among health care workers caring for him, patients who were being cared for at the same clinics or hospitals, and family members and visitors.

Some of these additional cases were in the same room as the index case; others were on the same ward. Though data are preliminary, exposure times that led to infection may have been as short as five minutes to a few hours. To date, two of these cases have been fatal.

Given the number of clinics and hospitals that cared for the index case, further cases can be expected.

On May 26, one of the confirmed cases with an exposure history in Korea traveled, against medical advice, to Guangdong, China, via Hong Kong. He was symptomatic at the time of travel. On May 29, China informed WHO that the patient, who was isolated at a Huizhou hospital, tested positive for the MERS coronavirus.

The occurrence of such a large outbreak outside the Middle East is a new development, as is exportation of the disease to a third country. The Ministry of Health has further reported that two recently confirmed cases represent a third generation of transmission – from the index case, to someone exposed to that case, to a third person with no direct exposure to the index case.

Consistent application of adequate measures for infection prevention and control has halted other large clusters of cases associated with healthcare facilities. WHO recommends that droplet precautions be added to standard measures when providing care to patients with symptoms of acute respiratory infections.

WHO does not advise special screening at points of entry nor does it currently recommend the application of any travel or trade restrictions.

MERS is a newly emerging disease that remains poorly understood. Much about the behavior of the virus remains shrouded in scientific uncertainty, though evidence is mounting that dromedary camels can transmit the virus to humans through close contact.

WHO says it is confident that investigations underway in Korea, including the sequencing of viruses and sharing of the findings, will contribute to further scientific understanding of this disease.

Source: WHO 

Related Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content